Rahaman Ademolu Ahmed, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nigeria | 7 | 2023 | 733 | 0.420 |
Why?
|
| RNA, Viral | 3 | 2021 | 2902 | 0.230 |
Why?
|
| Cefotaxime | 1 | 2022 | 35 | 0.220 |
Why?
|
| Immunogenetics | 1 | 2021 | 67 | 0.200 |
Why?
|
| Interinstitutional Relations | 1 | 2021 | 241 | 0.180 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 221 | 0.170 |
Why?
|
| HIV Infections | 2 | 2022 | 16718 | 0.160 |
Why?
|
| South Africa | 1 | 2022 | 1731 | 0.140 |
Why?
|
| Drug Resistance, Viral | 1 | 2020 | 820 | 0.130 |
Why?
|
| Cooperative Behavior | 1 | 2021 | 1504 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 1400 | 0.110 |
Why?
|
| Viral Load | 1 | 2022 | 3299 | 0.110 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 1587 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 2020 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4803 | 0.090 |
Why?
|
| Prevalence | 2 | 2022 | 15226 | 0.080 |
Why?
|
| Genomics | 1 | 2021 | 5720 | 0.060 |
Why?
|
| HIV-1 | 1 | 2020 | 6939 | 0.050 |
Why?
|
| beta-Globins | 1 | 2022 | 113 | 0.050 |
Why?
|
| Africa, Western | 1 | 2021 | 154 | 0.050 |
Why?
|
| Enterococcus | 1 | 2022 | 157 | 0.050 |
Why?
|
| Vaginal Smears | 1 | 2022 | 511 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 548 | 0.040 |
Why?
|
| Quality Control | 1 | 2020 | 841 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2022 | 694 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 631 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 667 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 1025 | 0.040 |
Why?
|
| Laboratories | 1 | 2020 | 463 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 1877 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2022 | 14722 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2022 | 1119 | 0.030 |
Why?
|
| Workflow | 1 | 2020 | 847 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1783 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2803 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 744343 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4751 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 2540 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2022 | 4217 | 0.020 |
Why?
|
| Base Sequence | 1 | 2021 | 12797 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3086 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3597 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4665 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5319 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10180 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 25043 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 35136 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 41006 | 0.010 |
Why?
|
| Middle Aged | 2 | 2022 | 213383 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2022 | 57776 | 0.010 |
Why?
|
| Young Adult | 1 | 2022 | 56430 | 0.010 |
Why?
|
| Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 85781 | 0.010 |
Why?
|
| Female | 2 | 2022 | 380194 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77449 | 0.010 |
Why?
|
| Aged | 1 | 2022 | 163280 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 214055 | 0.000 |
Why?
|
| Male | 1 | 2022 | 350118 | 0.000 |
Why?
|